About The Study: This randomized clinical trial of Chinese adults with overweight or obesity and with early type 2 diabetes found that an intermittent fasting plan consisting of two nonconsecutive fasting days and five days of habitual intake per week and meal replacement diet (5:2 MR) could improve glycemic outcomes and weight loss in the short term compared with metformin or empagliflozin, making it a promising initial intervention and early management for type 2 diabetes.
About The Study: This randomized clinical trial of Chinese adults with overweight or obesity and with early type 2 diabetes found that an intermittent fasting plan consisting of two nonconsecutive fasting days and five days of habitual intake per week and meal replacement diet (5:2 MR) could improve glycemic outcomes and weight loss in the short term compared with metformin or empagliflozin, making it a promising initial intervention and early management for type 2 diabetes.
Corresponding Author: To contact the corresponding author, Lixin Guo, M.D., email glx1218@163.com.
To access the embargoed study: Visit our For The Media website at this link
(doi:10.1001/jamanetworkopen.2024.16786)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Journal
JAMA Network Open
